# Oritavancin for CIED Infections With MDR Gram-positive Cocci

> **NCT07013552** · NA · NOT_YET_RECRUITING · sponsor: **Medical University of Silesia** · enrollment: 100 (estimated)

## Conditions studied

- Cardiac Implantable Electronic Device Infections
- Infective Endocarditis
- Multidrug-resistant Bacteria Screening
- Gram Positive Bacterial Infection
- Antibiotic Resistant Strain
- Antibiotic Therapy
- Healthcare Associated Infections

## Interventions

- **DRUG:** Administration of a single or repeated dose of a long half-life antibiotic - oritavancin
- **DRUG:** Administration of a repeated dose of a short half-life antibiotic - vancomycin

## Key facts

- **NCT ID:** NCT07013552
- **Lead sponsor:** Medical University of Silesia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-07
- **Final completion:** 2026-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07013552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07013552, "Oritavancin for CIED Infections With MDR Gram-positive Cocci". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07013552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*